I-MAB

Company

NovaBridge Biosciences

Filed

September 14, 2020

Accession Number

0000902664-20-003304

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →